VERWENDUNG VON 2-(2-NITRO-4-TRIFLUORMETHYLBENZOYL)-1,3-CYCLOHEXANDION ZUR BEHANDLUNG VON TYROSINÄMIE SOWIE PHARMAZEUTISCHE ZUSAMMENSETZUNGEN

The invention concerns novel pharmaceutical compositions containing as an active ingredient a 2-benzoyl-1,3-cyclohexanedione which is an inhibitor of the enzyme 4-hydroxyphenylpyruvate dioxygenase (HPPD). The compositions are valuable in the treating those disorders and diseases in which it is desir...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	MARKSTEDT, MAJ ELISABETH HOLME, S-427 00 BILLDAL, SE, ELLIS, MARTIN KEITH, MACCLESFIELD, CHESHIRE SK10 3QN, GB, LINDSTEDT, SVEN TORVALD, S-222 29 LUND, SE, LOCK, EDWARD ALAN, WILMSLOW, CHESHIRE SK9 5HD, GB, MUTTER, LINDA CAROL, BLOOMFIELD, CA 94952, US, PRISBYLLA, MICHAEL PAUL, RICHMOND, CA 94803, US
Format:	Patent
Sprache:	ger
Schlagworte:	ACYCLIC OR CARBOCYCLIC COMPOUNDS CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The invention concerns novel pharmaceutical compositions containing as an active ingredient a 2-benzoyl-1,3-cyclohexanedione which is an inhibitor of the enzyme 4-hydroxyphenylpyruvate dioxygenase (HPPD). The compositions are valuable in the treating those disorders and diseases in which it is desirable to intervene in the metabolic sequences catalysed by HPPD, such as in treating tyrosinemia type I.